06.16.26 -- Why FAT Should Confirm Alignment, Not Reveal Its Absence

Discover strategies to calibrate testing scope to risk, optimize execution workflows, and reduce operational burdens without compromising quality standards or safety compliance.

Aseptic drug manufacturing is going small. Read about how advanced robotic and automated systems with smaller footprints are changing the landscape and boosting accessibility.

As portfolios expand, production teams face mounting pressure to move faster. Learn how manufacturers are addressing rising complexity while maintaining performance across operations.

See how precise vent placement and microfiltration design optimize performance in life science devices, as well as practical troubleshooting strategies and a real-world case study.

Take a look at how standardized, modular production simplifies line integration, reduces engineering effort, and enables faster changeovers. Ideal for teams seeking flexible manufacturing models.

Early engagement with an expert packaging partner supports safe, cost-effective drug development and logistical success from precommercial stages through full market launch.

An overview of a milestone pharmaceutical outsourcing conference focused on CDMO collaboration, tech transfer, and oral solid and liquid dose manufacturing strategies.

Experts highlight spray drying as a gentle, scalable way to stabilize biologics, supporting high‑concentration injectables with controlled particles, sterility, and flexible delivery.

Integrating regulatory strategy with R&D planning early in drug development helps to minimize formulation risks and align manufacturing with compliance while preventing costly delays.

Chiral crystallization enables efficient production of enantiopure drug substances, improving pharmacological control and safety while supporting scalable small molecule development.

Master the shift to CSA and QMSR to reduce validation burdens by integrating systems and applying AI for predictive quality and operational excellence. Access the strategic roadmap today.

Find out how a global biopharmaceutical leader halved transcription errors and integrated over 350 instruments to accelerate the development of high-quality, clinically proven biosimilars.

Outlined here are the inherent benefits of PFS and how they relate to the delivery of drugs, how SARS-CoV-2 could be fueling an explosive increase in PFS demand, and how a CDMO is the key to success.

Leveraging computer-aided synthesis design technology and route scouting in the early stages of development can aid you in designing an efficient and cost-effective path to API manufacturing.